| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity
|
Jilek, Joseph L.
|
|
|
11 |
12 |
p. 3869-3878
|
artikel
|
| 2 |
A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer's disease
|
Lei, Ting
|
|
|
11 |
12 |
p. 4032-4044
|
artikel
|
| 3 |
Antibody–drug conjugates: Recent advances in linker chemistry
|
Su, Zheng
|
|
|
11 |
12 |
p. 3889-3907
|
artikel
|
| 4 |
A reporter gene assay for determining the biological activity of therapeutic antibodies targeting TIGIT
|
Fu, Zhihao
|
|
|
11 |
12 |
p. 3925-3934
|
artikel
|
| 5 |
A small molecule UPR modulator for diabetes identified by high throughput screening
|
Marrocco, Valeria
|
|
|
11 |
12 |
p. 3983-3993
|
artikel
|
| 6 |
Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1
|
Kong, Na
|
|
|
11 |
12 |
p. 4045-4054
|
artikel
|
| 7 |
Bile acid homeostasis in female mice deficient in Cyp7a1 and Cyp27a1
|
Rizzolo, Daniel
|
|
|
11 |
12 |
p. 3847-3856
|
artikel
|
| 8 |
Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo
|
Deng, Linglong
|
|
|
11 |
12 |
p. 3950-3965
|
artikel
|
| 9 |
Cover Story
|
|
|
|
11 |
12 |
p. xi
|
artikel
|
| 10 |
Deubiquitinase JOSD2 stabilizes YAP/TAZ to promote cholangiocarcinoma progression
|
Qian, Meijia
|
|
|
11 |
12 |
p. 4008-4019
|
artikel
|
| 11 |
DNA-PK inhibition by M3814 enhances chemosensitivity in non-small cell lung cancer
|
Wang, Manni
|
|
|
11 |
12 |
p. 3935-3949
|
artikel
|
| 12 |
Dual roles of p62/SQSTM1 in the injury and recovery phases of acetaminophen-induced liver injury in mice
|
Qian, Hui
|
|
|
11 |
12 |
p. 3791-3805
|
artikel
|
| 13 |
Editorial of Special Column on Drug- and Chemical-Induced Liver Injury
|
Luyendyk, James
|
|
|
11 |
12 |
p. 3684
|
artikel
|
| 14 |
Editor Profiles: Guest Editors of Special Column on Drug- and Chemical-Induced Liver Injury
|
|
|
|
11 |
12 |
p. 3683
|
artikel
|
| 15 |
Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns
|
Beier, Juliane I.
|
|
|
11 |
12 |
p. 3768-3778
|
artikel
|
| 16 |
Environmental toxicant-induced maladaptive mitochondrial changes: A potential unifying mechanism in fatty liver disease?
|
Schnegelberger, Regina D.
|
|
|
11 |
12 |
p. 3756-3767
|
artikel
|
| 17 |
Exogenous phosphatidic acid reduces acetaminophen-induced liver injury in mice by activating hepatic interleukin-6 signaling through inter-organ crosstalk
|
Clemens, Melissa M.
|
|
|
11 |
12 |
p. 3836-3846
|
artikel
|
| 18 |
Hepatotoxicity reports in the FDA adverse event reporting system database: A comparison of drugs that cause injury via mitochondrial or other mechanisms
|
Rana, Payal
|
|
|
11 |
12 |
p. 3857-3868
|
artikel
|
| 19 |
Mechanisms of immune checkpoint inhibitor-mediated liver injury
|
Shojaie, Layla
|
|
|
11 |
12 |
p. 3727-3739
|
artikel
|
| 20 |
Mechanistic studies of PEG-asparaginase-induced liver injury and hepatic steatosis in mice
|
Kumar, Gundala Venkata Naveen
|
|
|
11 |
12 |
p. 3779-3790
|
artikel
|
| 21 |
Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
|
Segovia-Zafra, Antonio
|
|
|
11 |
12 |
p. 3685-3726
|
artikel
|
| 22 |
Proteomics and metabolic phenotyping define principal roles for the aryl hydrocarbon receptor in mouse liver
|
Jin, Jian
|
|
|
11 |
12 |
p. 3806-3819
|
artikel
|
| 23 |
Recommendations for the use of the acetaminophen hepatotoxicity model for mechanistic studies and how to avoid common pitfalls
|
Jaeschke, Hartmut
|
|
|
11 |
12 |
p. 3740-3755
|
artikel
|
| 24 |
SARS-CoV-2 cell entry and targeted antiviral development
|
Chen, Zinuo
|
|
|
11 |
12 |
p. 3879-3888
|
artikel
|
| 25 |
Strategies to overcome drug resistance using SHP2 inhibitors
|
Liu, Meng
|
|
|
11 |
12 |
p. 3908-3924
|
artikel
|
| 26 |
Synergistic effects of autophagy/mitophagy inhibitors and magnolol promote apoptosis and antitumor efficacy
|
Tang, Yancheng
|
|
|
11 |
12 |
p. 3966-3982
|
artikel
|
| 27 |
Table of Contents
|
|
|
|
11 |
12 |
p. iii-x
|
artikel
|
| 28 |
Target-responsive subcellular catabolism analysis for early-stage antibody–drug conjugates screening and assessment
|
Sang, Hua
|
|
|
11 |
12 |
p. 4020-4031
|
artikel
|
| 29 |
The key role of gut–liver axis in pyrrolizidine alkaloid-induced hepatotoxicity and enterotoxicity
|
He, Yisheng
|
|
|
11 |
12 |
p. 3820-3835
|
artikel
|
| 30 |
TMEM16A inhibits angiotensin II-induced basilar artery smooth muscle cell migration in a WNK1-dependent manner
|
Zheng, Huaqing
|
|
|
11 |
12 |
p. 3994-4007
|
artikel
|
Tijdschrift beschrijving